(Q38195324)

30 August 2017

1 reference

title

Desensitization in kidney transplantation: review and future perspectives (English)

1 reference

30 August 2017

1 reference

5

E Steve Woodle

1 reference

30 August 2017

3

Rita R Alloway

1 reference

30 August 2017

Bassam G Abu Jawdeh

1

1 reference

PubMed ID

24621089

30 August 2017

Madison C Cuffy

series ordinal

2

1 reference

PubMed ID

24621089

30 August 2017

Adele Rike Shields

series ordinal

4

1 reference

30 August 2017

12 March 2014

1 reference

30 August 2017

Clinical Transplantation

1 reference

30 August 2017

28

1 reference

30 August 2017

4

1 reference

30 August 2017

494-507

1 reference

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

30 August 2017

1 reference

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

Desensitization protocols and their outcome

21 January 2018

1 reference

Plasmapheresis in the management of acute systemic lupus erythematosus?

21 January 2018

1 reference

Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome

21 January 2018

1 reference

Introduction and overview of therapeutic apheresis

21 January 2018

1 reference

Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy.

21 January 2018

1 reference

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action

21 January 2018

1 reference

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

21 January 2018

1 reference

Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis

21 January 2018

1 reference

Overcoming a positive crossmatch in living-donor kidney transplantation.

21 January 2018

1 reference

Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience

21 January 2018

1 reference

Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience

21 January 2018

1 reference

Positive cross-match living donor kidney transplantation: longer-term outcomes

21 January 2018

1 reference

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation

21 January 2018

1 reference

Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients

21 January 2018

1 reference

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

21 January 2018

1 reference

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

21 January 2018

1 reference

Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates

21 January 2018

1 reference

Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.

21 January 2018

1 reference

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.

21 January 2018

1 reference

Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies

21 January 2018

1 reference

Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients

21 January 2018

1 reference

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

21 January 2018

1 reference

The proteasome: structure, function, and role in the cell

21 January 2018

1 reference

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

21 January 2018

1 reference

The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma

21 January 2018

1 reference

Role of the unfolded protein response in cell death

21 January 2018

1 reference

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

21 January 2018

1 reference

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection

21 January 2018

1 reference

Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates

21 January 2018

1 reference

The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo.

21 January 2018

1 reference

Kidney paired donation and optimizing the use of live donor organs.

21 January 2018

1 reference

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.

21 January 2018

1 reference

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match

21 January 2018

1 reference

Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks.

21 January 2018

1 reference

Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CTR.12335

1 reference

30 August 2017

1 reference

PubMed ID

24621089